The Business Research Company’s report on the Amusement Parks Global Market Report 2025 Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
#How have key drivers contributed to the rapid growth of the genotyping assay market?
The increasing prevalence of genetic disorders is expected to propel the growth of the genotyping assay market going forward. Genetic disorders are a group of medical conditions that are caused by abnormalities or mutations in an individual’s deoxyribonucleic acid (DNA). Genotyping assays compare the DNA of affected people to that of healthy people to spot changes and can reveal specific genetic mutations or variations linked to a particular genetic disorder. For instance, in June 2023, Gene People, a UK-based registered charity organization supporting individuals with genetic conditions, reported that one in every 25 children in the UK had a genetic disorder, affecting approximately 30,000 newborns and young children in the country as well as more than 2.4 million children and adults annually. Therefore, the increasing prevalence of genetic disorders is driving the growth of the genotyping assay market.
Genotyping Assay Market Driver: Rising Demand For Personalized Medicine Drives Growth In The Genotyping Assay Market
Rising demand for personalized medicine is expected to propel the growth of the genotyping assay market going forward. Personalized medicine tailors medical treatment to an individual’s unique genetic makeup, offering more effective and precise healthcare interventions. Genotype assays are used in personalized medicine for analyzing individual’s genetic makeup to tailor medical treatments, drug selection, and dosages based on their unique genetic profile. For instance, in January 2023, according to the Food and Drug Administration, a US-based federal agency, the Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the rising demand for personalized medicine is driving the growth of the genotyping assay market.
Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp
How has the genotyping assay market size evolved, and what are the latest forecasts for its expansion?
The genotyping assay market size has grown exponentially in recent years. It will grow from $33.98 billion in 2024 to $41.6 billion in 2025 at a compound annual growth rate (CAGR) of 22.4%. The growth in the historic period can be attributed to traditional glassware usage, cultural and lifestyle influences, economic factors, hospitality and foodservice industry growth, gift and decor trends.
The genotyping assay market size is expected to see exponential growth in the next few years. It will grow to $95.5 billion in 2029 at a compound annual growth rate (CAGR) of 23.1%. The growth in the forecast period can be attributed to customization and personalization, health and wellness trends, e-commerce growth, smart and functional glassware, culinary and mixology trends. Major trends in the forecast period include material innovation, innovative shapes and designs, smart glassware, specialized glassware for beverages, health and safety features.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13444&type=smp
Which major companies dominate the genotyping assay market?
Major companies operating in the genotyping assay market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv Inc., Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., Integrated DNA Technologies Ltd., Sequenom Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies PLC, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs, TrimGen Corporation, Xcelris Genomics
What trends will shape the future of the generative design software market?
Major companies operating in the genotyping assay market are developing advancements in genomic research such as CE-IVD marked assay to detect treatment-resistant strains of HIV-1. CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit refers to a Sanger sequencing-based assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that may resist common antiretroviral therapeutics. For instance, in January 2023, Thermo Fisher Scientific, a US-based company launched CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit. This system detects treatment-resistant strains of HIV-1 and has unique features that include assessing genomic mutations, using HIV RNA, detecting drug resistance mutations, using gold-standard Sanger sequencing technology, and is designed for clinical use. The launch of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit has added value by improving the detection of treatment-resistant HIV-1 strains, providing ready-to-use reagents and controls, meeting regulatory requirements, having high-performance characteristics, and being compatible with existing sequencing platforms and workflows.
Which region dominates the genotyping assay market, and what factors contribute to its leadership?
North America was the largest region in the genotyping assay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report
How is the genotyping assay market segmented, and which segment holds the largest share?
The genotyping assay market covered in this report is segmented –
1) By Product And Service: Reagents And Kits, Genotyping Services, Instruments, Bioinformatics
2) By Technology: Microarrays, Polymerase Chain Reaction, Sequencing, Capillary Electrophoresis, Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry, Other Technologies
3) By End-User: Pharmacogenomics, Personalized Medicine And Diagnostics, Animal Genetics, Agricultural Biotechnology, Research And Diagnostic Laboratories, Academic Institutes
Subsegments:
1) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Genotyping Services, Genotyping by PCR, Whole Genome Sequencing Services, SNP Genotyping Services
2) By Instruments: PCR Machines, Sequencing Instruments, Microarrays
3) By Bioinformatics: Data Analysis Software, Genotyping Data Management Tools
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13444
What defines the structure and scope of the genotyping assay market?
A genotyping assay is a laboratory technique or method used to determine an individual’s genetic makeup at specific genetic loci or positions within their DNA. It identifies and analyzes genetic variations, such as single nucleotide polymorphisms (SNPs) or insertions or deletions, that exist in an individual’s genome.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
